Skip to main content
Erschienen in: PharmacoEconomics 5/2000

01.11.2000 | Current Opinion

The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research

How Meaningful is it?

verfasst von: Prof. Ron D. Hays, J. Michael Woolley

Erschienen in: PharmacoEconomics | Ausgabe 5/2000

Einloggen, um Zugang zu erhalten

Abstract

It is generally believed that small differences in health-related quality of life (HR-QOL) may be statistically significant yet clinically unimportant. The concept of the minimal clinically meaningful difference (MCID) has been proposed to refer to the smallest difference in a HR-QOL score that is considered to be worthwhile or clinically important.
However, there is danger in oversimplification in asking the question: what is the MCID on this HR-QOL instrument? We argue that the attempt to define a single MCID is problematic for a number of reasons and recommend caution in the search for the MCID holy grail. Specifically, absolute thresholds are suspect because they ignore the cost or resources required to produce a change in HR-QOL. In addition, there are several practical problems in estimating the MCID, including: (i) the estimated magnitude varies depending on the distributional index and the external standard or anchor; (ii) the amount of change might depend on the direction of change; and (iii) the meaning of change depends on where you start (baseline value).
Literatur
1.
Zurück zum Zitat Jaeschke R, Singer J, Guyatt G. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407–15PubMedCrossRef Jaeschke R, Singer J, Guyatt G. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407–15PubMedCrossRef
2.
Zurück zum Zitat Van Walraven C, Mahon JL, Moher D, et al. Surveying physicians to determine the minimal important difference: implications for sample-size calculation. J Clin Epidemiol 1999; 52: 717–23PubMedCrossRef Van Walraven C, Mahon JL, Moher D, et al. Surveying physicians to determine the minimal important difference: implications for sample-size calculation. J Clin Epidemiol 1999; 52: 717–23PubMedCrossRef
3.
Zurück zum Zitat Blackwelder WC. Similarity/equivalence trials for combination vaccines. Ann N Y Acad Sci 1995; 754: 321–8PubMedCrossRef Blackwelder WC. Similarity/equivalence trials for combination vaccines. Ann N Y Acad Sci 1995; 754: 321–8PubMedCrossRef
4.
Zurück zum Zitat Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15 (2): 141–55PubMedCrossRef Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15 (2): 141–55PubMedCrossRef
5.
Zurück zum Zitat Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36: I. Conceptual framework and item selection. Med Care 1992; 30: 473–83PubMedCrossRef Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36: I. Conceptual framework and item selection. Med Care 1992; 30: 473–83PubMedCrossRef
6.
Zurück zum Zitat Hays RD, Hadorn D. Responsiveness to change: An aspect of validity, not a separate dimension. Qual Life Res 1992; 1: 73–5PubMedCrossRef Hays RD, Hadorn D. Responsiveness to change: An aspect of validity, not a separate dimension. Qual Life Res 1992; 1: 73–5PubMedCrossRef
8.
Zurück zum Zitat Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. London: Academic Press, 1988 Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. London: Academic Press, 1988
9.
Zurück zum Zitat Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol 1997; 50: 239–46PubMedCrossRef Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol 1997; 50: 239–46PubMedCrossRef
10.
Zurück zum Zitat Barber BL, Santanello NC, Epstein RS. Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Qual Life Res 1996; 5: 117–22PubMedCrossRef Barber BL, Santanello NC, Epstein RS. Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Qual Life Res 1996; 5: 117–22PubMedCrossRef
11.
Zurück zum Zitat Ware JE, Snow K, Kosinski M, et al. SF-36 Health Survey: manual and interpretation guide. Boston (MA): The Health Institute, 1993 Ware JE, Snow K, Kosinski M, et al. SF-36 Health Survey: manual and interpretation guide. Boston (MA): The Health Institute, 1993
12.
Zurück zum Zitat Baker DW, Hays RD, Brook RH. Understanding changes in health status: is the floor phenomenon merely the last step of the staircase? Med Care 1997; 35: 1–15PubMedCrossRef Baker DW, Hays RD, Brook RH. Understanding changes in health status: is the floor phenomenon merely the last step of the staircase? Med Care 1997; 35: 1–15PubMedCrossRef
13.
Zurück zum Zitat Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user’s manual. Boston (MA): The Health Institute, 1994 Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user’s manual. Boston (MA): The Health Institute, 1994
14.
Zurück zum Zitat Lansky D, Butler JB, Waller FT. Using health status measures in the hospital setting: from acute care to ‘outcomes management. ’ Med Care 1992; 30 (5 Suppl.): MS57–73 Lansky D, Butler JB, Waller FT. Using health status measures in the hospital setting: from acute care to ‘outcomes management. ’ Med Care 1992; 30 (5 Suppl.): MS57–73
15.
Zurück zum Zitat Rampal P, Martin C, Marquis P, et al. A quality of life study in five hundred and eighty-one duodenal ulcer patients: maintenance versus intermittent treatment with nizatidine. Scand J Gastroenterol 1994; 206: 44–51CrossRef Rampal P, Martin C, Marquis P, et al. A quality of life study in five hundred and eighty-one duodenal ulcer patients: maintenance versus intermittent treatment with nizatidine. Scand J Gastroenterol 1994; 206: 44–51CrossRef
Metadaten
Titel
The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research
How Meaningful is it?
verfasst von
Prof. Ron D. Hays
J. Michael Woolley
Publikationsdatum
01.11.2000
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 5/2000
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200018050-00001

Weitere Artikel der Ausgabe 5/2000

PharmacoEconomics 5/2000 Zur Ausgabe

Adis Pharmacoeconomic Drug Evaluation

Inhaled Fluticasone Propionate